肝胆相照论坛

 

 

肝胆相照论坛 论坛 English&English 存档 1 [注意]来自《亚洲企业责任公司周刊 》的特别报道:中国 ...
查看: 852|回复: 13

[注意]来自《亚洲企业责任公司周刊 》的特别报道:中国乙肝:歧视何时是尽头? 感谢美丽大眼睛的辛苦工作! [复制链接]

Rank: 9Rank: 9Rank: 9

现金
8760 元 
精华
10 
帖子
3790 
注册时间
2004-10-22 
最后登录
2011-12-7 

荣誉之星 天天开星

1
发表于 2005-3-11 01:01

以下是翻译自《亚洲企业责任公司周刊 》的报道:

中国乙肝:歧视何时是尽头?

中国是世界上感染率最高的乙肝大国之一。而乙肝病毒(以下简称HBV),除了可对身体健康产生致命威胁之外,乙肝病毒携带者目前所面临的在就业制度方面的歧视也是极其严峻的。这些歧视主要体现在HBV携带都在某些领域(尤其是政府部门)很难获得就业机会。尽管HBV的问题近些年来在英文媒体上还算不上什么热点话题,但在国内已经开始吸引越来越多关注的目光。例如,2003年,中国媒体广泛报道了一名浙江大学的毕业生在得知由于自己是乙肝病毒携带者(HBVER)而在公务员选拔中落选后,气急之下,用随身携带的水果刀将一名人事官员刺死,另一名刺成重伤。最后,他本人也被判处死刑;另一名安徽青年由于HBV检测呈阳性被拒绝录取为公务员后将当地政府告上法庭的事件也成为媒体关注的热点。

尽管在中国大陆各类媒体和由HBVER及其权益支持者组建的网站上对这类事件已经进行了广泛报道,但对许多外国公司来说,乙肝歧视问题仍显得很陌生。很多来华投资的外商并不知道国内严格的入职体检意味着什么,他们根本不会想到这些他们看来很常规的检查会成为审查求职者的一种工具并且让HBVER失去工作的机会。

然而,最近当中国政府修改了公务员录取规定中有关乙肝病毒携带者录用的有关条款后,外企的HBVER员工的入职体检问题再不是冰山一角了。作为私企的表率,外资企业应当率先意识到这一变革的重大意义,这样才能确保新的规定才能在全国得到全方位有效彻底的实施。本文将对今年一月开始实施的这份新的规定进行概述,同时也会介绍一些乙肝病毒的简要知识。

其实对乙肝病毒携带者的就业歧视现象可以追溯到国内早先颁布的许多规章中,其中有一些甚至根本未提及“乙肝”等相关字样。例如,在1994年由国家人事部出台的《国家公务员录用暂行规定》中列明了政府机关录用公务员的各项标准,但对体检标准没有明确指示,只是在第二十六条中这样写到:“体检的项目、合格标准及有关办法由录用主管机关根据职位要求具体规定。 ”

在上世纪九十年代中期,人们对HBV的认识是非常贫乏的,即使是政府机关的工作人员也不太清楚肝炎的传染途径。直至今日,还有许多人错误的认为,所有类型的肝炎(甲肝、乙肝、丙肝、丁肝和戍肝)均会通过日常接触传染。因此,大多数政府机构要求在入职体检中必须进行病毒的血清检验。凡在检测中HBV呈阳性者将会失去被录取成为政府公务员的资格。最为典型的例子就是,湖南省自1995年颁布的体检标准中就明确规定:在HBV血清检测呈阳性者不予录取为公务员。

自2000年开始,公众开始渐渐意识到其实乙型肝炎并不会通过日常的接触传染。与此同时,通过各界人士通过互联网进行有组织的科普宣传和教育,消除对乙肝病原携带者的歧视的呼声也日渐高涨。政府机构也开始放宽录用体检的标准以便让一些乙肝病原携带者能够参与到公务员的选拔中来。2004年,国家人事部和卫生部制定了新版的体检试行标准,在征询了公众和专业人士意见后,新的体检标准自2005年1月19日开始正式施行,其中第七条的修改格外引人注目,它规定:各种急慢性肝炎,不合格。乙肝病原携带者,经检查排除肝炎的,合格。

通过对比在2004年发布的试行草案可以更有助于我们对这一修改加深理解。草案中规定:急性肝炎康复后谷丙转氨酶及谷草转氨酶(见下方)持续半年以上维持正常者,合格。慢性肝炎康复后谷丙转氨酶及谷草转氨酶持续两年维持正常者,合格。乙肝病毒或丙肝病毒呈阳性,但谷丙转氨酶及谷草转氨酶正常者,合格。

总而言之,肝功能正常者或是在一定时期内肝损坏程度得到了控制者,均有机会参与公务员选拔。这对所有的乙肝病原携带者来说都是一个利好消息。但是,许多人依旧担心的是由于新的规定并没有取消对乙肝病毒的血清检测, 而为此地方政府仍旧可能用各种理由将乙肝病毒携带者拒之门外。如今HBVER依然在努力敦促政府立法取消强制性的乙肝病毒血清检测,他们引用了国际劳工组织章程中反对对艾滋病毒(HIV)携带者进行就业歧视的相关规定:雇主在建立雇佣关系时及在将来的工作过程中,不得要求员工进行HIV检测。在常规健康体检中也不得包括HIV病毒检测。所以一些有前瞻性的公司有望考虑免去HBV病毒的血清检测。

(续)

[此贴子已经被作者于2005-3-11 18:33:26编辑过]

哪个九十七岁死,奈何桥上等三年。

Rank: 9Rank: 9Rank: 9

现金
8760 元 
精华
10 
帖子
3790 
注册时间
2004-10-22 
最后登录
2011-12-7 

荣誉之星 天天开星

2
发表于 2005-3-12 08:21

Hepatitis B in China: The end of discrimination?

---CSR Asia staff [email protected]

China has one of the world’s highest infection rates for hepatitis B (see boxes below for more information). Apart from being a serious medical condition that can lead to death, hepatitis B virus (HBV) carriers also face discriminatory workplace regulations and practices that make finding or holding a job difficult in a range of sectors (particularly the civil service). Although rarely making headlines in the English-language media, HBV has become a prominent issue in China over the last couple of years.

For instance, in 2003 the Chinese press extensively covered the story of a college graduate from Zhejiang who stabbed an official to death and badly injured another over the rejection of his job application for the civil service on the basis of being a HBV carrier (HBVer); he was sentenced to death and executed as a result. In Anhui, the story of a young man who sued the local government for rejecting his job application for being HBV positive made headlines.

Despite high profile coverage in the Chinese media and online (Internet communities linking HBVers and their supporters abound on mainland), there is little awareness by foreign companies of the discrimination faced by HBVers. Few foreign investors or buyers know about the strict pre-employment medical checks most job applicants must undergo, or that these are used to screen applicants and deny jobs to HBVers. Routine testing is also used to unearth employed HBVers and terminate their employment.

All of this might be of only marginal interest if it were not for the fact that regulations concerning pre-employment checks for civil service applicants with HBV have just changed. Foreign companies in particular should be aware of changes in these regulations that act as a model for private and other enterprises, and ensure that those changes are effectively implemented. This piece is a short outline of the regulatory amendments that came into force in January, and includes some quick facts and definitions about the virus itself.

The origins of workplace discrimination against HBVers can be found in a set of regulations that - ironically - make no mention of HBV (or any medical condition) at all. In 1994, China’s Ministry of Personnel published the “Employment Regulations for National Civil Service Applicants.” These regulations outlined the criteria by which applicants should be admitted to government employment, but they contained no items or standards relating specifically to reemployment medical check-ups. What they did contain, however, was Article 26, which prescribed that departments could determine their own regulations regarding pre-employment

The level of awareness about HBV in the mid-regulations on medical 1990s was poor. Most people, including those in check-ups might like to government departments, were poorly informed consider dispensing with about transmission methods. As is still some-HBV testing altogether”times the case today, employers wrongly believed all types of the hepatitis virus (A, B, C, D, E, F and G) could be transmitted through casual daily contact. As a result, most local governmental bodies included a mandatory HBV serologic test in their pre-employment medical check-up. Applicants testing positive on the HBV serologic tests were excluded from civil service positions. A typical example of these regulations can be found in Hunan’s medical check-up standards from 1995 that stated: “Applicants returning abnormal results for the HBV serologic test are not qualified for government positions.”

By 2000, public awareness campaigns had alerted people to the fact that hepatitis B could not be transmitted by casual contact. The plea to eliminate discrimination towards HBV carriers became stronger, which was partly the result of well-organised online communities who published factual information and organised grass roots educations campaigns. Governmental bodies started to modify medical check-up standards with an emphasis on relaxing regulations that would enable more people to have access to employment in the civil service. In 2004, the Ministry of Personnel and the Ministry of Health released the first draft of a new general medical check-up standard. After a consultation period involving the public and academics, the new medical check-up standard came into force on 19 January 2005. The key is Article 7, which states in full: “Applicants with any form of acute or chronic hepatitis are not qualified. HBV carriers qualify if they are not diagnosed as having hepatitis.”

This requires some explanation, for which reference to the draft regulations issued last year is helpful. The draft regulations stated that “Applicants who have recovered from acute hepatitis are qualified, if their ALT and AST [see box above for definitions] have been in the normal range for more than half a year.

Those who have recovered from chronic hepatitis are also qualified, if their ALT and AST have been in the normal level for more than 2 years. Applicants who test positive for the hepatitis B or hepatitis C virus identification test (including HbsAg, HbeAg, …) are qualified, if their ALT and AST are at the normal level.”

In short, if tests show that liver function is within normal levels and/or liver damage (as measured by ALT and AST) is within normal levels for the indicated periods, then the applicant is qualified to enter the civil service. This is good news for all HBV carriers. However, many are still worried that since the new regulations do not forbid the use of HBV serologic tests, local government bodies may still be able to disqualify HBV carriers using other means. HVBers are still urging the government to dispense with mandatory testing for HBV completely. They point to the International Labour Organisation’s (ILO’s) code of Practice on Employment and HIV/AIDS, which states in Article 8.1: “Prohibition in recruitment and employment: HIV testing should not be required at the time of recruitment or as a condition of continued employment. Any routine medical testing, such as testing for fitness carried out prior to the commencement of employment or on a regular basis for workers, should not include mandatory HIV testing.” Companies wishing to move beyond the new regulations on medical check-ups might like to consider dispensing with HBV testing altogether.

[此贴子已经被作者于2005-3-11 18:34:21编辑过]

哪个九十七岁死,奈何桥上等三年。

Rank: 9Rank: 9Rank: 9

现金
8760 元 
精华
10 
帖子
3790 
注册时间
2004-10-22 
最后登录
2011-12-7 

荣誉之星 天天开星

3
发表于 2005-3-12 08:27

乙型肝炎小知识

乙肝是目前世界上感染率最高的肝脏疾病,它是由乙肝病毒(HBV)所致。它的传染途径包括血液传播、无保护性行为、共用针头或母婴传播。但它并不会通过打喷嚏,咳嗽,拥抱或是进食由乙肝患者烹煮的食物这些日常行为而感染。目前世界有20亿急性乙肝感染者,4亿慢性乙肝感染者,在中国约有1.2亿慢性乙肝感染者。每年有一百万人死于由乙肝导致的肝癌和肝硬化。

乙肝关键词

急性乙肝病毒感染者:指的是在感染乙肝病毒半年以下的患者,在此期间患者可能不显示肝病临床体症但具备传染性。90%的成人感染者可自愈并产生抗体,并且在将来不会被感染。

慢性乙肝病毒感染者:指的是乙肝病毒表面抗原呈阳性且ALT和AST高于正常值持续半年以上者。在中国有20%-50%的慢性乙肝感染者最终死于与病毒发作导致的疾病。

乙肝病毒表面抗原(HBSAG):它是乙肝病毒的外壳蛋白,如果它呈阳性,则说明体内乙肝病毒感染的存在。

乙肝病毒e抗原(HBEAG):它是病毒传染性强的标志,此项指标与乙肝病毒复制密切相关,它有助于慢性乙肝感染者的预后治疗。

天冬氨酸转氨酶(AST):俗称谷草转氨酶,主要存在于肝脏及心肌中,是用于考量肝脏受损程度的一项指标。

丙氨酸转氨酶(ALT):俗称谷丙转氨酶,它是由受损肝细胞释放到血液中的一种酶类,也可以反映肝脏受损程度,但较AST而言,ALT反映肝脏炎症的准确性更高,因为除肝脏外,人的心脏内也会产生AST。在慢性肝炎病人的常规肝功能检查中均包括了ALT检测,这项指标同时也有助于反映病人在一定时期内的治疗及康复效果。

2005年4月,亚洲企业责任公司周刊将会刊出一份关于HBV状况及相关政策架构的详尽报告,其中还会论述到最佳的人事管理倡议。

[此贴子已经被作者于2005-3-11 18:31:40编辑过]

哪个九十七岁死,奈何桥上等三年。

Rank: 9Rank: 9Rank: 9

现金
8760 元 
精华
10 
帖子
3790 
注册时间
2004-10-22 
最后登录
2011-12-7 

荣誉之星 天天开星

4
发表于 2005-3-12 08:29

HEPATITIS B: Quick facts

Hepatitis B is the world's most common liver infection and is caused by the hepatitis B virus (HBV) It is transmitted through blood, unprotected sex, shared or re-used needles, or from infected mothers to their newborn babies during delivery (the same as HIV) Hepatitis B is not transmitted casually; it cannot be spread through sneezing, coughing, hugging or eating food prepared by someone who is infected with hepatitis B .

There are around 2 billion carriers worldwide (people with acute hepatitis B) Approximately 400 million people have chronic hepatitis B (see below for definition of acute and chronic) Around 120 million people in China have chronic hepatitis B (one source puts the number

as high as 170 million) 1 million people die every year from hepatitis B, mainly from cirrhosis of the liver and liver cancer.

HEPATITIS B: Quick definitions

Acute hepatitis B: refers to the first six months of infection, during which patients may or may not exhibit symptoms but are able to pass the virus. 90% of healthy adults will recover during this stage and develop protective antibodies against future hepatitis infections Chronic hepatitis B: A patient who tests positive for the hepatitis B virus with raised ALT and AST levels for more than 6 months is considered to have a chronic hepatitis B infection. In China, between 20-50% of chronic sufferers will die from HBV-related diseases HBsAG (Hepatitis B Surface Antigen): The surface protein of the hepatitis B virus that is used as a marker to detect infection. If this blood test proves to be positive, then the hepatitis B virus is present

HBeAG: A marker of a high degree of HBV infectivity, it correlates with a high level of HBV replication. It is primarily used to help determine the clinical management of patients with chronic HBV infection AST (Aspartate Aminotransferase): An enzyme that is released into the blood by the liver and other tissues or organs. It is generally used as a marker for liver damage ALT (Alanine Aminotransferase): An enzyme that is released into the blood by damaged liver cells. It is used as a marker for liver cell damage. The ALT test is considered to be a more accurate reflection of liver inflammation than AST because other organs such as the heart can also produce AST. ALT levels are included in the regular monitor ring of all chronic hepatitis B patients; this test can also be useful in deciding whether a patient would benefit from therapy or evaluating the effectiveness of an ongoing treatment.

In April 2005 CSR Asia will publish a complete report on HBV and the regulatory framework, including a section specifying best human resource management practice.

[此贴子已经被作者于2005-3-11 18:34:49编辑过]

哪个九十七岁死,奈何桥上等三年。

Rank: 9Rank: 9Rank: 9

现金
8760 元 
精华
10 
帖子
3790 
注册时间
2004-10-22 
最后登录
2011-12-7 

荣誉之星 天天开星

5
发表于 2005-3-12 08:36
此帖在权益版已经被置顶,给战友带来鼓舞。谢谢大眼睛和关注论坛对外交流的战友。[em09][em09][em09][em09]

[此贴子已经被作者于2005-3-11 18:36:59编辑过]


哪个九十七岁死,奈何桥上等三年。

Rank: 8Rank: 8

现金
12341 元 
精华
帖子
6710 
注册时间
2004-11-2 
最后登录
2007-7-18 
6
发表于 2005-3-12 11:31

beautiful big eyes is excellent .

doing these needs much knowledge and time

I think I can't do it well

生活总是会给我们希望,给我们惊喜-------明天一定会更好!

Rank: 7Rank: 7Rank: 7

现金
8672 元 
精华
11 
帖子
2432 
注册时间
2004-12-22 
最后登录
2008-8-6 
7
发表于 2005-3-13 05:59

谢谢香孜的校订。也欢迎大家多提意见。

[em06][em06]
走在一起,是缘份,一起在走,是幸福........

Rank: 3Rank: 3

现金
311 元 
精华
帖子
61 
注册时间
2005-1-25 
最后登录
2007-6-1 
8
发表于 2005-3-13 23:37
大家想办法把此文章让更多的人看到。我已把它转到网易论坛并发到部分公司人事部油箱。

Rank: 8Rank: 8

现金
3943 元 
精华
帖子
834 
注册时间
2005-2-25 
最后登录
2008-2-24 
9
发表于 2005-3-13 23:41

我把这篇报道发给了我们公司副经理,不知道他会不会看,或者看了是否后有点启发。

Sow a seed and the earth will yield a flower. Dream your dream to the sky and it will bring you your beloved. 播下一颗种子 ,大地将为你生长出鲜花。向天空许下一个心愿,天空会把你心爱的人带到你面前。

Rank: 4

现金
3938 元 
精华
帖子
386 
注册时间
2005-1-21 
最后登录
2009-5-5 
10
发表于 2005-3-13 23:55
谢谢香孜 !!
在种子不及的地方寻找花朵 我们要在心不及的地方寻找理解
‹ 上一主题|下一主题

肝胆相照论坛

GMT+8, 2024-7-11 08:34 , Processed in 0.019396 second(s), 12 queries , Gzip On.

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.